Library / Laws / 118th Congress / Senate Bills / S. 2886
S. 2886
To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2023-09-21 | 1.2K | ⠃⠗⠋ |